The base-case analyses demonstrate that, when focusing solely on their cardiovascular benefits, GLP-1 RAs were not cost-effective in either the total or secondary prevention populations
In the trial involving 2,339 patients, with a BMI of or higher than 35, all doses of retatrutide met the primary and key secondary endpoints for delivering clinically meaningful weight loss
PCOS-GWAS susceptibility variants in THADA, INSR, TOX3, and DENND1A are associated with metabolic syndrome or insulin resistance in women with PCOS
It smoothens the face and skin and makes it appear more attractive
For the cofirst authorship, BW is named first, as she initiated and designed the study
Some patients who don't respond well to one medication do better on the other